JAMES A WELKER D.O.
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine
- Where
- BELFAST, ME
- NPI
- 1568423440
- Received
- $16,779 in 64 records, 2019 to 2025 ($12,179 general, $4,600 research)
- As principal investigator
- $810,608 of research payments to others in 664 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 2 | $31 |
| 2024 | General payment | 9 | $2,536 |
| 2023 | Research payment | 3 | $350 |
| 2021 | General payment | 1 | $1,000 |
| 2020 | General payment | 4 | $1,059 |
| 2020 | Research payment | 1 | $4,250 |
| 2019 | General payment | 44 | $7,551 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $4,610 | 2019–2020 |
| Actelion Pharmaceuticals, Ltd | 1 | $4,250 | 2020 |
| CSL Behring | 15 | $2,890 | 2019 |
| Boston Scientific Corporation | 8 | $2,507 | 2024 |
| Novo Nordisk AS | 13 | $1,367 | 2019–2023 |
| Merck Sharp & Dohme LLC | 1 | $1,000 | 2021 |
| Shire North American Group Inc | 2 | $33 | 2019 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 | 2024 |
| ACADIA Pharmaceuticals Inc | 1 | $17 | 2019 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 | 2019 |
| La Jolla Pharmaceutical Company | 1 | $16 | 2025 |
| Tandem Diabetes Care, Inc. | 1 | $15 | 2025 |
| Gilead Sciences, Inc. | 1 | $13 | 2019 |
| Novo Nordisk Inc | 1 | $10 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Travel and Lodging | 13 | $5,216 |
| Research payment | 4 | $4,600 |
| Consulting Fee | 2 | $3,968 |
| Food and Beverage | 45 | $2,994 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-09-23 | Tandem Diabetes Care, Inc. | $15 | Food and Beverage | In-kind items and services | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-02-12 | La Jolla Pharmaceutical Company | $16 | Food and Beverage | In-kind items and services | GIAPREZA Drug, EMERGENT HYPOTENSION | 2025 | |
| 2024-07-05 | Boston Scientific Corporation | $270 | Travel and Lodging | Cash or cash equivalent | EkoSonic Device, EkoSonic_PI | 2024 | |
| 2024-07-05 | Boston Scientific Corporation | $101 | Food and Beverage | Cash or cash equivalent | EkoSonic Device, EkoSonic_PI | 2024 | |
| 2024-06-08 | Boston Scientific Corporation | $186 | Food and Beverage | In-kind items and services | EkoSonic Device, EkoSonic_PI | 2024 | |
| 2024-06-07 | Boston Scientific Corporation | $430 | Travel and Lodging | In-kind items and services | EkoSonic Device, EkoSonic_PI | 2024 | |
| 2024-06-07 | Boston Scientific Corporation | $270 | Food and Beverage | In-kind items and services | EkoSonic Device, EkoSonic_PI | 2024 | |
| 2024-06-07 | Boston Scientific Corporation | $158 | Food and Beverage | In-kind items and services | EkoSonic Device, EkoSonic_PI | 2024 | |
| 2024-06-06 | Boston Scientific Corporation | $658 | Travel and Lodging | In-kind items and services | EkoSonic Device, EkoSonic_PI | 2024 | |
| 2024-06-06 | Boston Scientific Corporation | $430 | Travel and Lodging | In-kind items and services | EkoSonic Device, EkoSonic_PI | 2024 | |
| 2024-04-03 | Mallinckrodt Hospital Products Inc. | $28 | Food and Beverage | In-kind items and services | TERLIVAZ Drug, CRITICAL CARE | 2024 | |
| 2023-11-12 | Novo Nordisk AS | $259 | Research payment | In-kind items and services | Ozempic Drug, Diabetes | NN SELECT Results Meeting Philadelphia | 2023 |
| 2023-11-12 | Novo Nordisk AS | $57 | Research payment | In-kind items and services | Ozempic Drug, Diabetes | NN SELECT Results Meeting Philadelphia | 2023 |
| 2023-11-12 | Novo Nordisk AS | $33 | Research payment | In-kind items and services | Ozempic Drug, Diabetes | NN SELECT Results Meeting Philadelphia | 2023 |
| 2021-07-26 | Merck Sharp & Dohme LLC | $1,000 | Consulting Fee | Cash or cash equivalent | Biological, INFECTIOUS DISEASE | 2021 | |
| 2020-04-08 | Actelion Pharmaceuticals, Ltd | $4,250 | Research payment | Cash or cash equivalent | Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea | 2020 | |
| 2020-02-27 | Novartis Pharmaceuticals Corporation | $1,019 | Travel and Lodging | In-kind items and services | 2020 | ||
| 2020-02-21 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2020 | |
| 2020-01-24 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2020 | |
| 2020-01-10 | Novartis Pharmaceuticals Corporation | $9 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2020 | |
| 2019-11-15 | Novartis Pharmaceuticals Corporation | $10 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-11-08 | Novo Nordisk AS | $101 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-11-08 | Novo Nordisk AS | $101 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-11-08 | Novo Nordisk AS | $101 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-11-08 | Novo Nordisk AS | $101 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-11-08 | Novo Nordisk AS | $101 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-11-08 | Novo Nordisk AS | $101 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-11-08 | Novo Nordisk AS | $101 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-11-08 | Novo Nordisk AS | $101 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-11-08 | Novo Nordisk AS | $101 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-11-08 | Novo Nordisk AS | $101 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-10-16 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-09-13 | Novartis Pharmaceuticals Corporation | $12 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-09-11 | Shire North American Group Inc | $12 | Food and Beverage | In-kind items and services | NATPARA (PARATHYROID HORMONE) Drug, INTERNAL MEDICINE | 2019 | |
| 2019-08-19 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-08-12 | Novartis Pharmaceuticals Corporation | $7 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-07-30 | ACADIA Pharmaceuticals Inc | $17 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2019 | |
| 2019-07-24 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2019 | |
| 2019-07-12 | Novartis Pharmaceuticals Corporation | $11 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-06-26 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-06-14 | Novartis Pharmaceuticals Corporation | $2,968 | Consulting Fee | Cash or cash equivalent | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-06-14 | Novartis Pharmaceuticals Corporation | $297 | Travel and Lodging | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-06-14 | Novartis Pharmaceuticals Corporation | $134 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-06-14 | Novartis Pharmaceuticals Corporation | $27 | Travel and Lodging | Cash or cash equivalent | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-06-14 | Novartis Pharmaceuticals Corporation | $16 | Travel and Lodging | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-05-16 | CSL Behring | $980 | Travel and Lodging | In-kind items and services | 2019 | ||
| 2019-05-16 | CSL Behring | $115 | Travel and Lodging | In-kind items and services | 2019 | ||
| 2019-05-16 | CSL Behring | $24 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-05-16 | CSL Behring | $6 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-05-15 | CSL Behring | $129 | Travel and Lodging | Cash or cash equivalent | 2019 | ||
| 2019-05-15 | CSL Behring | $80 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-05-15 | CSL Behring | $27 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-05-14 | CSL Behring | $238 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-05-14 | CSL Behring | $93 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-05-14 | CSL Behring | $80 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-05-13 | CSL Behring | $725 | Travel and Lodging | In-kind items and services | 2019 | ||
| 2019-05-13 | CSL Behring | $238 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-05-13 | CSL Behring | $115 | Travel and Lodging | In-kind items and services | 2019 | ||
| 2019-05-13 | CSL Behring | $27 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-05-13 | CSL Behring | $9 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-05-08 | Shire North American Group Inc | $21 | Food and Beverage | In-kind items and services | NATPARA (PARATHYROID HORMONE) Drug, INTERNAL MEDICINE | 2019 | |
| 2019-04-03 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-02-06 | Gilead Sciences, Inc. | $13 | Food and Beverage | In-kind items and services | Ranexa Drug, IHD | 2019 | |
| 2019-01-23 | Avanir Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, pseudobulbar affect (PBA) | 2019 |
Research payments naming this person as principal investigator
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Belfast, ME, county Waldo County, ME, state Maine; placed by its city name.
| Measure | Place (city or town) Belfast, ME | County Waldo County, ME | State Maine |
|---|---|---|---|
| Population B01003 | 6,986 | 40,192 | 1,387,817 |
| Population, 2020 census P1 | 6,938 | 39,607 | 1,362,359 |
| Median age B01002 | 60.6 | 47.4 | 44.8 |
| Under 18 B01001 | 14.2% | 17.7% | 18.1% |
| 65 and over B01001 | 39.1% | 25.1% | 22.4% |
| Households B11001 | 3,400 | 17,470 | 597,159 |
| Foreign born B05002 | 4.9% | 2.3% | 4.1% |
| Median household income B19013 | $67,679 | $72,782 | $74,733 |
| Median family income B19113 | $82,141 | $87,896 | $96,912 |
| Per capita income B19301 | $48,291 | $40,336 | $43,742 |
| Poverty rate B17001 | 16.0% | 12.0% | 10.7% |
| Unemployment rate B23025 | 0.6% | 3.7% | 3.8% |
| Civilian labor force B23025 | 2,602 | 19,647 | 719,683 |
| Mean commute (minutes) B08013 | 21.5 | 26.6 | 24.6 |
| Bachelor's degree or higher B15003 | 42.9% | 34.4% | 36.2% |
| Housing units B25001 | 4,300 | 22,252 | 751,876 |
| Owner-occupied B25003 | 68.5% | 81.9% | 74.3% |
| Renters B25003 | 31.5% | 18.1% | 25.7% |
| Median home value B25077 | $340,900 | $257,700 | $296,600 |
| Median gross rent B25064 | $962 | $1,021 | $1,139 |
| White, not Hispanic B03002 | 89.8% | 92.8% | 89.9% |
| Black B03002 | 0.0% | 0.4% | 1.8% |
| Hispanic or Latino B03002 | 2.0% | 1.6% | 2.2% |
| Asian B03002 | 0.5% | 0.5% | 1.1% |
| American Indian and Alaska Native B03002 | 0.0% | 0.2% | 0.3% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Belfast, ME.
Comments